Abstract
The relative failure of symptomatic therapeutic trials for Alzheimer's disease using non-selective cholinergic agonists brings about the need for longitudinal studies with parallel designs aimed at disease stabilization, using trophic substances or amyloid suppressors. © 1991, Canadian Neurological Sciences Federation. All rights reserved.
Cite
CITATION STYLE
APA
Gauthier, S., Gauthier, L., Bouchard, R., Quirion, R., & Sultan, S. (1991). Treatment of Alzheimer’s Disease: Hopes and Reality. Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques, 18(S3), 439–441. https://doi.org/10.1017/S0317167100032637
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free